Immunotherapy and Immune Responses

94 та иш

Cellular vesicles-based “all-in-one” vaccine platform triggers mucosal immunity against respiratory viruses
Yanrong Gao, Jie Zhu, Jimao Zhai +7
МақолаBacterial Infections and VaccinesNano Today20240 иқтибос
ABI
Recent advancements of nanoparticles for antiviral therapy
Priyanku Pradip Das, Sounok Sengupta, Deepak Balram +5
МақолаRNA Interference and Gene DeliveryAdvances in Natural Sciences Nanoscience and Nanotechnology20240 иқтибос
ABI
Vaccination and modern therapy of cervical cancer
G. G. Khakimova
МақолаCervical Cancer and HPV ResearchMedical alphabet20240 иқтибос
ABI
Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions
Chou‐Yi Hsu, Harikumar Pallathadka, Saade Abdalkareem Jasim +7
Шарҳ мақолаCAR-T cell therapy researchCritical Reviews in Oncology/Hematology20240 иқтибос
ABI
Exploring the modulation of TLR4 and its associated ncRNAs in cancer immunopathogenesis, with an emphasis on the therapeutic implications and mechanisms underlying drug resistance
Mohammad Y. Alshahrani, Enwa Felix Oghenemaro, Jasur Rizaev +7
Шарҳ мақолаImmune Response and InflammationHuman Immunology20240 иқтибос
ABI
Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?
Manh-Cuong Vo, Van-Dinh-Huan Tran, Van‐Tan Nguyen +5
МақолаCAR-T cell therapy researchJournal of Hematology & Oncology20250 иқтибос
ABI
Engineering CAR T NK and NKT cell therapies to target cancer stem cells and overcome stem like resistance
Omer Qutaiba B. Allela, Abdulkareem Shareef, S. Renuka Jyothi +9
МақолаCAR-T cell therapy researchDiscover Oncology20250 иқтибос
ABI
Current trends on immunotherapy for oncology
Neya Kavya Chander, A Prashannalakshmi, Phanish Chandra Ravi +4
МақолаImmunotherapy and Immune ResponsesBioinformation20250 иқтибос
ABI
In Vivo Interrogation of Cell-Penetrating Peptide Function: Accumulation in Tumors and the Potential as a Specific PET Probe
Zhan Si, Lulu Tian, Hongxin Zhou +2
МақолаRNA Interference and Gene DeliveryBioconjugate Chemistry20250 иқтибос
ABI
Immuno-oncology approaches to overcome T cell exhaustion in melanoma
Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Mohammad Y. Alshahrani, Muzdalifa Mejbel Fedwi +7
МақолаCancer Immunotherapy and BiomarkersSeminars in Oncology20250 иқтибос
ABI
RAK KASALLIGIGA QARSHI IMMUNOTERAPIYA: ZAMONAVIY YUTUQLAR
Xoliqberdiyeva Zebo Rasuljon qizi
МақолаImmunotherapy and Immune ResponsesZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
ABI
RAK KASALLIGIGA QARSHI IMMUNOTERAPIYA: ZAMONAVIY YUTUQLAR
Xoliqberdiyeva Zebo Rasuljon qizi
МақолаImmunotherapy and Immune ResponsesZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
ABI
RAK KASALLIGIGA QARSHI IMMUNOTERAPIYA: ZAMONAVIY YUTUQLAR
Kudratova Nozanin
МақолаImmunotherapy and Immune ResponsesZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
ABI
RAK KASALLIGIGA QARSHI IMMUNOTERAPIYA: ZAMONAVIY YUTUQLAR
Kudratova Nozanin
МақолаImmunotherapy and Immune ResponsesZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
ABI
AUTOIMMUN GIPOTERIOZNING INGICHKA ICHAK FERMENTLARI VA SO‘RILISHIGA TA’SIRI
Lyubov KUCHKAROVA, Sevara Berdiyorova
МақолаImmunotherapy and Immune ResponsesŬzMU habarlari.20250 иқтибос
ABI
AUTOIMMUN TIREOIDIT VA SELEN
Dilorom Urunbayeva, Shaxnoza Xudaybergenova
МақолаT-cell and B-cell Immunology20250 иқтибос
ABI
REVMATOLOGIYADA ANTI-SIKLIK SITRULINLANGAN PEPTID (ASSP) VA REVMATIK FAKTOR(RF) KO'RSATGICHLARINING DIFFERENSIAL DIAGNOSTIK AHAMIYATI
Soliyev, Muhammadqodir Abdugaffor o'g'li, To'raxo'jayev, Bobur Hamidovich, Mirabdullayev, Ibrohim Axmadjonovich +2
МақолаAtherosclerosis and Cardiovascular DiseasesZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
ABI
REVMATOLOGIYADA ANTI-SIKLIK SITRULINLANGAN PEPTID (ASSP) VA REVMATIK FAKTOR(RF) KO'RSATGICHLARINING DIFFERENSIAL DIAGNOSTIK AHAMIYATI
Soliyev, Muhammadqodir Abdugaffor o'g'li, To'raxo'jayev, Bobur Hamidovich, Mirabdullayev, Ibrohim Axmadjonovich +2
МақолаAtherosclerosis and Cardiovascular DiseasesZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
ABI
CHAQALOQLAR GEMOLIGIK KASALLIGI
Xolmurodov Inoyatullo, Islomova Rushana
МақолаImmunotherapy and Immune ResponsesZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
ABI
CHAQALOQLAR GEMOLIGIK KASALLIGI
Xolmurodov Inoyatullo, Islomova Rushana
МақолаImmunotherapy and Immune ResponsesZenodo (CERN European Organization for Nuclear Research)20250 иқтибос
ABI
Tumor Microenvironment‐Responsive Nanomedicines for Potentiating Cancer Immunotherapy
Qianqian Huang, Fan Tong, Jiantao Chen +5
Шарҳ мақолаNanoplatforms for cancer theranosticsAdvanced Science20250 иқтибос
ABI
Regulatory T Cells in Colon Cancer: Implications for Pathogenesis, Prognosis and Emerging Therapeutic Strategies
Faris Anad Muhammad, Abdulkareem Shareef, S. Renuka Jyothi +10
Шарҳ мақолаT-cell and B-cell ImmunologyImmunological Investigations20250 иқтибос
ABI
Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies
Omer Qutaiba B. Allela, Ali Fawzi Al-Hussainy, Gaurav Sanghvi +9
Шарҳ мақолаCancer Immunotherapy and BiomarkersNaunyn-Schmiedeberg s Archives of Pharmacology20250 иқтибос
ABI
Harnessing organoid technology to model autoimmune pathways in rheumatological and inflammatory disorders
Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Teeba Ammar Rashid, Paul Rodrigues +7
Шарҳ мақолаImmunotherapy and Immune ResponsesNaunyn-Schmiedeberg s Archives of Pharmacology20250 иқтибос
ABI
Nanovaccines against Cervical Cancer: Reliable Strategies to Circumvent Limitations of Traditional Therapeutic Vaccines
Felix Oghenemaro Enwa, Safia Obaidur Rab, Ebraheem Abdu Musad Saleh +7
Шарҳ мақолаRNA Interference and Gene DeliveryAdvanced Pharmaceutical Bulletin20250 иқтибос
ABI